Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial.

Brener SJ, Lembo NJ, Kandzari DE, Sabaté M, Gershlick AH, Banning AP, Buszman PE, Kosmidou I, Simonton CA, Morice MC, Ben-Yehuda O, Dressler O, Zhang Z, Sabik JF 3rd, Kappetein AP, Serruys PW, Stone GW.

Catheter Cardiovasc Interv. 2020 Mar 17. doi: 10.1002/ccd.28858. [Epub ahead of print]

PMID:
32181569
2.

One-Year Outcomes After Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention: The T-TIME Randomized Trial.

Maznyczka AM, McCartney PJ, Eteiba H, Greenwood JP, Muir DF, Chowdhary S, Gershlick AH, Appleby C, Cotton JM, Wragg A, Curzen N, Oldroyd KG, Lindsay M, McEntegart M, Rocchiccioli JP, Shaukat A, Good R, Watkins S, Robertson K, Malkin C, Martin L, Gillespie L, Weir RA, Ford TJ, Petrie MC, Murphy A, Petrie CJ, Ramparsad N, Wetherall K, Fox KA, Ford I, McConnachie A, Berry C; T-TIME Group.

Circ Cardiovasc Interv. 2020 Feb;13(2):e008855. doi: 10.1161/CIRCINTERVENTIONS.119.008855. Epub 2020 Feb 11. No abstract available.

PMID:
32069113
3.

Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial.

Giustino G, Serruys PW, Sabik JF 3rd, Mehran R, Maehara A, Puskas JD, Simonton CA, Lembo NJ, Kandzari DE, Morice MC, Taggart DP, Gershlick AH, Ragosta M 3rd, Kron IL, Liu Y, Zhang Z, McAndrew T, Dressler O, Généreux P, Ben-Yehuda O, Pocock SJ, Kappetein AP, Stone GW.

JACC Cardiovasc Interv. 2020 Feb 10;13(3):375-387. doi: 10.1016/j.jcin.2019.09.019. Epub 2020 Jan 15.

PMID:
31954680
4.

Chronic infarct size after spontaneous coronary artery dissection: implications for pathophysiology and clinical management.

Al-Hussaini A, Abdelaty AMSEK, Gulsin GS, Arnold JR, Garcia-Guimaraes M, Premawardhana D, Budgeon C, Wood A, Natarajan N, Mangion K, Rakhit R, Hoole SP, Johnson TW, Berry C, Hudson I, Gershlick AH, Ladwiniec A, Kovac J, Squire I, Samani NJ, Plein S, McCann GP, Adlam D.

Eur Heart J. 2020 Jan 3. pii: ehz895. doi: 10.1093/eurheartj/ehz895. [Epub ahead of print]

PMID:
31898721
5.

Difficulties in undertaking research in acutely ill cardiac patients.

López-Sobrino T, Gershlick AH.

Eur Heart J. 2019 Dec 23. pii: ehz857. doi: 10.1093/eurheartj/ehz857. [Epub ahead of print] No abstract available.

PMID:
31872262
6.

Clinical outcomes of patients discharged from the Rapid Access Chest Pain Clinic with non-anginal chest pain: A retrospective cohort study.

Kite TA, Gaunt H, Banning AS, Roberts E, Kovac J, Hudson I, Gershlick AH.

Int J Cardiol. 2020 Mar 1;302:1-4. doi: 10.1016/j.ijcard.2019.12.008. Epub 2019 Dec 6.

PMID:
31864788
7.

Spotlight on N-STEMI ACS: getting the right patients the right treatment, and at the right time.

Kite TA, Gersh BJ, Gershlick AH.

EuroIntervention. 2019 Dec 20;15(12):e1041-e1045. doi: 10.4244/EIJV15I12A196. No abstract available.

8.

Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial.

Gershlick AH, Banning AS, Parker E, Wang D, Budgeon CA, Kelly DJ, Kane PO, Dalby M, Hetherington SL, McCann GP, Greenwood JP, Curzen N.

J Am Coll Cardiol. 2019 Dec 24;74(25):3083-3094. doi: 10.1016/j.jacc.2019.10.033.

PMID:
31856964
9.

Procedural Characteristics and Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Left Main Trifurcation Disease: The EXCEL trial.

Kandzari DE, Gershlick AH, Serruys PW, Leon MB, Morice MC, Simonton CA, Lembo NJ, Mansour S, Sabaté M, Sabik JF 3rd, Kappetein AP, Dressler O, Stone GW.

EuroIntervention. 2019 Dec 3. pii: EIJ-D-19-00686. doi: 10.4244/EIJ-D-19-00686. [Epub ahead of print]

10.

Full Revascularization in the Patient With ST-Segment Elevation Myocardial Infarction: The Story So Far.

Gershlick AH, Price MJ.

J Am Coll Cardiol. 2019 Dec 3;74(22):2724-2727. doi: 10.1016/j.jacc.2019.10.022. No abstract available.

PMID:
31779787
11.

Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes.

Milojevic M, Serruys PW, Sabik JF 3rd, Kandzari DE, Schampaert E, van Boven AJ, Horkay F, Ungi I, Mansour S, Banning AP, Taggart DP, Sabaté M, Gershlick AH, Bochenek A, Pomar J, Lembo NJ, Noiseux N, Puskas JD, Crowley A, Kosmidou I, Mehran R, Ben-Yehuda O, Généreux P, Pocock SJ, Simonton CA, Stone GW, Kappetein AP.

J Am Coll Cardiol. 2019 Apr 9;73(13):1616-1628. doi: 10.1016/j.jacc.2019.01.037.

PMID:
30947913
12.

Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club.

Galassi AR, Werner GS, Boukhris M, Azzalini L, Mashayekhi K, Carlino M, Avran A, Konstantinidis NV, Grancini L, Bryniarski L, Garbo R, Bozinovic N, Gershlick AH, Rathore S, Di Mario C, Louvard Y, Reifart N, Sianos G.

EuroIntervention. 2019 Jun 20;15(2):198-208. doi: 10.4244/EIJ-D-18-00826.

13.

Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.

McCartney PJ, Eteiba H, Maznyczka AM, McEntegart M, Greenwood JP, Muir DF, Chowdhary S, Gershlick AH, Appleby C, Cotton JM, Wragg A, Curzen N, Oldroyd KG, Lindsay M, Rocchiccioli JP, Shaukat A, Good R, Watkins S, Robertson K, Malkin C, Martin L, Gillespie L, Ford TJ, Petrie MC, Macfarlane PW, Tait RC, Welsh P, Sattar N, Weir RA, Fox KA, Ford I, McConnachie A, Berry C; T-TIME Group.

JAMA. 2019 Jan 1;321(1):56-68. doi: 10.1001/jama.2018.19802.

14.

Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention.

Kandzari DE, Gershlick AH, Serruys PW, Leon MB, Morice MC, Simonton CA, Lembo NJ, Banning AP, Merkely B, van Boven AJ, Ungi I, Kappetein AP, Sabik JF 3rd, Généreux P, Dressler O, Stone GW.

Circ Cardiovasc Interv. 2018 Oct;11(10):e007007. doi: 10.1161/CIRCINTERVENTIONS.118.007007.

PMID:
30354633
15.

Invasive cardiovascular needs in South Africa: a view from afar up close.

Holmes DR Jr, King S, Gershlick AH, Marco J, Koolen J, Pichard A, Bassand JP, Kettles DI, Wijns W, Ntsekhe M.

EuroIntervention. 2018 Oct 20;14(8):852-855. doi: 10.4244/EIJV14I8A153. No abstract available.

16.

Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.

Giustino G, Mehran R, Serruys PW, Sabik JF 3rd, Milojevic M, Simonton CA, Puskas JD, Kandzari DE, Morice MC, Taggart DP, Gershlick AH, Généreux P, Zhang Z, McAndrew T, Redfors B, Ragosta M 3rd, Kron IL, Dressler O, Leon MB, Pocock SJ, Ben-Yehuda O, Kappetein AP, Stone GW.

J Am Coll Cardiol. 2018 Aug 14;72(7):754-765. doi: 10.1016/j.jacc.2018.05.057.

17.

Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).

Joner M, Koppara T, Byrne RA, Castellanos MI, Lewerich J, Novotny J, Guagliumi G, Xhepa E, Adriaenssens T, Godschalk TC, Malik N, Alfonso F, Tada T, Neumann FJ, Desmet W, Ten Berg JM, Gershlick AH, Feldman LJ, Massberg S, Kastrati A; Prevention of PRESTIGE Investigators.

JACC Cardiovasc Interv. 2018 Jul 23;11(14):1340-1350. doi: 10.1016/j.jcin.2018.02.029.

18.

Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site: Results From the EXCEL Trial.

Gershlick AH, Kandzari DE, Banning A, Taggart DP, Morice MC, Lembo NJ, Brown WM 3rd, Banning AP, Merkely B, Horkay F, van Boven AJ, Boonstra PW, Dressler O, Sabik JF 3rd, Serruys PW, Kappetein AP, Stone GW.

JACC Cardiovasc Interv. 2018 Jul 9;11(13):1224-1233. doi: 10.1016/j.jcin.2018.03.040.

19.

A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.

Werner GS, Martin-Yuste V, Hildick-Smith D, Boudou N, Sianos G, Gelev V, Rumoroso JR, Erglis A, Christiansen EH, Escaned J, di Mario C, Hovasse T, Teruel L, Bufe A, Lauer B, Bogaerts K, Goicolea J, Spratt JC, Gershlick AH, Galassi AR, Louvard Y; EUROCTO trial investigators.

Eur Heart J. 2018 Jul 7;39(26):2484-2493. doi: 10.1093/eurheartj/ehy220.

PMID:
29722796
20.

The value of Guidelines in everyday clinical practice.

Gershlick AH.

Eur Heart J. 2018 Apr 1;39(13):1046-1048. doi: 10.1093/eurheartj/ehy103. No abstract available.

PMID:
29618034
21.

STEMI - are we there yet?

Gershlick AH.

EuroIntervention. 2018 Mar 20;13(16):1869-1873. doi: 10.4244/EIJV13I16A304. No abstract available.

22.

Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry.

Godschalk TC, Byrne RA, Adriaenssens T, Malik N, Feldman LJ, Guagliumi G, Alfonso F, Neumann FJ, Trenk D, Joner M, Schulz C, Steg PG, Goodall AH, Wojdyla R, Dudek D, Wykrzykowska JJ, Hlinomaz O, Zaman AG, Curzen N, Dens J, Sinnaeve P, Desmet W, Gershlick AH, Kastrati A, Massberg S, Ten Berg JM; PRESTIGE Investigators.

JACC Cardiovasc Interv. 2017 Dec 26;10(24):2548-2556. doi: 10.1016/j.jcin.2017.09.019.

23.

Contemporary considerations in left main stem treatment.

Gershlick AH, Banning A.

EuroIntervention. 2017 Nov 20;13(10):1144-1147. doi: 10.4244/EIJV13I10A179. No abstract available.

24.

What Can We Do About Cardiogenic Shock?

Gershlick AH, Banning AS.

Circ Cardiovasc Interv. 2017 Nov;10(11). pii: e006020. doi: 10.1161/CIRCINTERVENTIONS.117.006020. No abstract available.

PMID:
29146673
25.

A SENIOR moment? Bare-metal stents in elderly patients.

Gerber RT, Gershlick AH.

Lancet. 2018 Jan 6;391(10115):4-6. doi: 10.1016/S0140-6736(17)32803-9. Epub 2017 Nov 1. No abstract available.

PMID:
29102363
26.

Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort).

Adriaenssens T, Joner M, Godschalk TC, Malik N, Alfonso F, Xhepa E, De Cock D, Komukai K, Tada T, Cuesta J, Sirbu V, Feldman LJ, Neumann FJ, Goodall AH, Heestermans T, Buysschaert I, Hlinomaz O, Belmans A, Desmet W, Ten Berg JM, Gershlick AH, Massberg S, Kastrati A, Guagliumi G, Byrne RA; Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort (PRESTIGE) Investigators.

Circulation. 2017 Sep 12;136(11):1007-1021. doi: 10.1161/CIRCULATIONAHA.117.026788. Epub 2017 Jul 18.

27.

Management of Multivessel Disease and Cardiogenic Shock.

Banning AS, Gershlick AH.

Interv Cardiol Clin. 2016 Oct;5(4):533-540. doi: 10.1016/j.iccl.2016.06.009. Epub 2016 Aug 13. Review.

PMID:
28582001
28.

Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention.

Barton GR, Irvine L, Flather M, McCann GP, Curzen N, Gershlick AH; CvLPRIT Investigators.

Value Health. 2017 Jun;20(6):745-751. doi: 10.1016/j.jval.2017.02.002. Epub 2017 Mar 22.

29.

A risk scoring system to predict coronary stent thrombosis.

Malik N, Banning AS, Belger M, Fakhouri W, Graham-Clarke PL, Banning A, Baumbach A, Blackman DJ, de Belder A, Lefèvre T, Stables R, Zaman A, Gershlick AH.

Curr Med Res Opin. 2017 May;33(5):859-867. doi: 10.1080/03007995.2017.1292680. Epub 2017 Mar 9.

PMID:
28276254
30.

Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.

Veitch AM, Vanbiervliet G, Gershlick AH, Boustiere C, Baglin TP, Smith LA, Radaelli F, Knight E, Gralnek IM, Hassan C, Dumonceau JM.

Endoscopy. 2016 Apr;48(4):c1. doi: 10.1055/s-0042-122686. Epub 2017 Jan 23. No abstract available.

PMID:
28114689
32.

Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study.

Khan JN, Nazir SA, Greenwood JP, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman D, Ring A, Peebles C, Wong J, Sasikaran T, Flather M, Swanton H, Gershlick AH, McCann GP.

J Cardiovasc Magn Reson. 2016 Nov 9;18(1):85.

33.

Prasugrel hydrochloride for the treatment of acute coronary syndrome patients.

Gunarathne A, Hussain S, Gershlick AH.

Expert Rev Cardiovasc Ther. 2016 Nov;14(11):1215-1226. doi: 10.1080/14779072.2016.1245145. Review.

PMID:
27701930
34.

Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II Trial.

Sotomi Y, Ishibashi Y, Suwannasom P, Nakatani S, Cho YK, Grundeken MJ, Zeng Y, Tateishi H, Smits PC, Barragan P, Kornowski R, Gershlick AH, Windecker S, van Geuns RJ, Bartorelli AL, de Winter RJ, Tijssen J, Serruys PW, Onuma Y.

JACC Cardiovasc Interv. 2016 Jun 27;9(12):1216-27. doi: 10.1016/j.jcin.2016.03.022. Epub 2016 Jun 20.

35.

Ischemia and Infarction in STEMI Patients With Multivessel Disease: Insights From the CvLPRIT Nuclear Substudy.

Kelion AD, Pakkal MV, Chowdhury FU, Birchall JD, Dixon KL, Lai FY, Kelly DJ, Flather M, McCann GP, Gershlick AH.

J Am Coll Cardiol. 2016 Jun 7;67(22):2698-9. doi: 10.1016/j.jacc.2016.03.544. No abstract available.

36.

Infarct Size Following Treatment With Second- Versus Third-Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST-Segment Elevation Myocardial Infarction in the CvLPRIT Study.

Khan JN, Greenwood JP, Nazir SA, Lai FY, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman D, Peebles C, Wong J, Flather M, Swanton H, Gershlick AH, McCann GP.

J Am Heart Assoc. 2016 May 31;5(6). pii: e003403. doi: 10.1161/JAHA.116.003403.

37.

Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial.

Nazir SA, McCann GP, Greenwood JP, Kunadian V, Khan JN, Mahmoud IZ, Blackman DJ, Been M, Abrams KR, Shipley L, Wilcox R, Adgey AA, Gershlick AH.

Eur Heart J. 2016 Jun 21;37(24):1910-9. doi: 10.1093/eurheartj/ehw136. Epub 2016 May 4.

38.

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L; DAPT Study Investigators.

JAMA. 2016 Apr 26;315(16):1735-49. doi: 10.1001/jama.2016.3775. Erratum in: JAMA. 2016 Jul 19;316(3):350. JAMA. 2016 Jul 19;316(3):350.

39.

Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.

Veitch AM, Vanbiervliet G, Gershlick AH, Boustiere C, Baglin TP, Smith LA, Radaelli F, Knight E, Gralnek IM, Hassan C, Dumonceau JM.

Endoscopy. 2016 Apr;48(4):385-402. doi: 10.1055/s-0042-102652. Epub 2016 Feb 18. Erratum in: Endoscopy. 2016 Apr;48(4):c1.

40.

Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.

Veitch AM, Vanbiervliet G, Gershlick AH, Boustiere C, Baglin TP, Smith LA, Radaelli F, Knight E, Gralnek IM, Hassan C, Dumonceau JM.

Gut. 2016 Mar;65(3):374-89. doi: 10.1136/gutjnl-2015-311110.

41.

The randomised Complete versus Lesion-only PRimary percutaneous coronary Intervention Trial: Cardiovascular Magnetic Resonance imaging substudy (CvLPRIT-CMR).

McCann GP, Khan JN, Greenwood JP, Nazir SA, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman DJ, Ring A, Peebles C, Wong J, Sasikaran T, Flather M, Swanton H, Gershlick AH.

Southampton (UK): NIHR Journals Library; 2016 Jan.

42.

A propensity matched comparison of return to work and quality of life after stenting or coronary artery bypass surgery.

Maznyczka AM, Howard JP, Banning AS, Gershlick AH.

Open Heart. 2016 Jan 13;3(1):e000322. doi: 10.1136/openhrt-2015-000322. eCollection 2016.

43.

Data supporting the use of the radial approach as the default strategy in octogenarians undergoing primary-PCI?

Gunarathne A, Alahmar A, Gershlick AH.

Int J Cardiol. 2016 Apr 1;208:60-4. doi: 10.1016/j.ijcard.2016.01.117. Epub 2016 Jan 11.

PMID:
26828382
44.

Implications of ischaemic area at risk and mode of reperfusion in ST-elevation myocardial infarction.

Bainey KR, Fresco C, Zheng Y, Halvorsen S, Carvalho A, Ostojic M, Goldstein P, Gershlick AH, Westerhout CM, Van de Werf F, Armstrong PW; STREAM Investigators.

Heart. 2016 Apr;102(7):527-33. doi: 10.1136/heartjnl-2015-308075. Epub 2016 Jan 18.

PMID:
26783237
45.

Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium.

Riegger J, Byrne RA, Joner M, Chandraratne S, Gershlick AH, Ten Berg JM, Adriaenssens T, Guagliumi G, Godschalk TC, Neumann FJ, Trenk D, Feldman LJ, Steg PG, Desmet W, Alfonso F, Goodall AH, Wojdyla R, Dudek D, Philippi V, Opinaldo S, Titova A, Malik N, Cotton J, Jhagroe DA, Heestermans AA, Sinnaeve P, Vermeersch P, Valina C, Schulz C, Kastrati A, Massberg S; Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort (PRESTIGE) Investigators.

Eur Heart J. 2016 May 14;37(19):1538-49. doi: 10.1093/eurheartj/ehv419. Epub 2015 Aug 30.

46.

Complete revascularisation in patients with ST-segment elevation myocardial infarction and multivessel disease: contemporary data in context.

Banning AS, Gershlick AH.

Evid Based Med. 2016 Apr;21(2):73-4. doi: 10.1136/ebmed-2015-110315. Epub 2016 Jan 4. No abstract available.

PMID:
26729774
47.

Complete Versus Lesion-Only Primary PCI: The Randomized Cardiovascular MR CvLPRIT Substudy.

McCann GP, Khan JN, Greenwood JP, Nazir S, Dalby M, Curzen N, Hetherington S, Kelly DJ, Blackman DJ, Ring A, Peebles C, Wong J, Sasikaran T, Flather M, Swanton H, Gershlick AH.

J Am Coll Cardiol. 2015 Dec 22;66(24):2713-2724. doi: 10.1016/j.jacc.2015.09.099.

48.

Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.

Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; DAPT Study Investigators.

JACC Cardiovasc Interv. 2015 Oct;8(12):1552-62. doi: 10.1016/j.jcin.2015.05.026. Erratum in: JACC Cardiovasc Interv. 2015 Dec 21;8(14):1913.

49.

Reply: Culprit Artery Only or Multivessel Primary PCI: The Debate Continues.

Kelly DJ, Gershlick AH, Greenwood JP, McCann GP.

J Am Coll Cardiol. 2015 Oct 13;66(15):1745-6. doi: 10.1016/j.jacc.2015.06.1350. No abstract available.

50.

Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?

Shavadia J, Zheng Y, Dianati Maleki N, Huber K, Halvorsen S, Goldstein P, Gershlick AH, Wilcox R, Van de Werf F, Armstrong PW.

J Am Heart Assoc. 2015 Aug 24;4(8):e002049. doi: 10.1161/JAHA.115.002049.

Supplemental Content

Loading ...
Support Center